Market Tracker

04/23 6:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.73
Data as of Apr 23
 -0.02 / -1.14%
Today’s Change
1.11
Today|||52-Week Range
3.31
-16.43%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.75
Today’s open1.75
Day’s range1.68 - 1.78
Volume785,243
Average volume (3 months)1,041,729
Market cap$256.0M
Dividend yield--
Data as of 4:05pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)-8.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...-0.22-5.06%
GALEGalena Biopharma Inc+0.21+10.10%
MRTXMirati Therapeutics ...-0.61-3.08%
CCXIChemoCentryx Inc-0.18-3.01%
Data as of 3:59pm ET, 04/23/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Jerome Pykett
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts